questionsmedicales.fr
Maladies du système nerveux
Maladies du système nerveux central
Encéphalopathies
Épilepsie
Syndromes épileptiques
Épilepsies myocloniques
Épilepsies myocloniques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Épilepsie
Électroencéphalographie
Crises épileptiques
Symptômes neurologiques
Électroencéphalographie
Épilepsie
Symptômes
5
Myoclonies
Crises épileptiques
Myoclonies
Symptômes neurologiques
Crises épileptiques
Épilepsie
Épilepsie
Variabilité des symptômes
Crises nocturnes
Épilepsie
Prévention
5
Prévention des crises
Épilepsie
Déclencheurs de crises
Stress
Éducation des patients
Épilepsie
Activité physique
Sécurité
Traitements
5
Anticonvulsivants
Traitement de l'épilepsie
Thérapie comportementale
Diète cétogène
Évaluation du traitement
Épilepsie
Traitement à long terme
Épilepsie
Effets secondaires
Anticonvulsivants
Complications
5
Complications
Troubles psychologiques
Soutien psychologique
Thérapies
Facteurs de risque
5
Facteurs de risque
Traumatismes crâniens
Troubles neurologiques
Épilepsie
Stress
Déclencheurs de crises
Infections cérébrales
Méningite
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épilepsies myocloniques : Questions médicales les plus fréquentes",
"headline": "Épilepsies myocloniques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épilepsies myocloniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-27",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épilepsies myocloniques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Syndromes épileptiques",
"url": "https://questionsmedicales.fr/mesh/D000073376",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes épileptiques",
"code": {
"@type": "MedicalCode",
"code": "D000073376",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.493"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Épilepsies myocloniques progressives",
"alternateName": "Myoclonic Epilepsies, Progressive",
"url": "https://questionsmedicales.fr/mesh/D020191",
"about": {
"@type": "MedicalCondition",
"name": "Épilepsies myocloniques progressives",
"code": {
"@type": "MedicalCode",
"code": "D020191",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.493.063.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Épilepsie myoclonique juvénile",
"alternateName": "Myoclonic Epilepsy, Juvenile",
"url": "https://questionsmedicales.fr/mesh/D020190",
"about": {
"@type": "MedicalCondition",
"name": "Épilepsie myoclonique juvénile",
"code": {
"@type": "MedicalCode",
"code": "D020190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.493.063.670"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Épilepsies myocloniques",
"alternateName": "Epilepsies, Myoclonic",
"code": {
"@type": "MedicalCode",
"code": "D004831",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pasquale Striano",
"url": "https://questionsmedicales.fr/author/Pasquale%20Striano",
"affiliation": {
"@type": "Organization",
"name": "IRCCS Istituto \"Giannina Gaslini\", Genova, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy."
}
},
{
"@type": "Person",
"name": "Marte Syvertsen",
"url": "https://questionsmedicales.fr/author/Marte%20Syvertsen",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Drammen Hospital, Vestre Viken Health Trust, Oslo, Norway."
}
},
{
"@type": "Person",
"name": "Deb K Pal",
"url": "https://questionsmedicales.fr/author/Deb%20K%20Pal",
"affiliation": {
"@type": "Organization",
"name": "Department of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Jeanette Koht",
"url": "https://questionsmedicales.fr/author/Jeanette%20Koht",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Drammen Hospital, Vestre Viken Health Trust, Oslo, Norway."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Efficacy and safety of esophageal submucosal tumors treated with internal traction method-assisted submucosal tunneling endoscopic resection: a single-center, single-blind, randomized controlled study.",
"datePublished": "2022-12-12",
"url": "https://questionsmedicales.fr/article/36509948",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00464-022-09813-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study.",
"datePublished": "2023-04-08",
"url": "https://questionsmedicales.fr/article/37689449",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jebdp.2023.101863"
}
},
{
"@type": "ScholarlyArticle",
"name": "Melatonin for migraine prevention in children and adolescents: A randomized, double-blind, placebo-controlled trial after single-blind placebo lead-in.",
"datePublished": "2023-07-19",
"url": "https://questionsmedicales.fr/article/37466211",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/head.14600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ultrasound predictors of difficult spinal anesthesia: a prospective single-blind observational study.",
"datePublished": "2023-02-21",
"url": "https://questionsmedicales.fr/article/36800810",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23736/S0375-9393.22.16990-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Attention neuroenhancement through tDCS or neurofeedback: a randomized, single-blind, controlled trial.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36266396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22245-6"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Épilepsie",
"item": "https://questionsmedicales.fr/mesh/D004827"
},
{
"@type": "ListItem",
"position": 6,
"name": "Syndromes épileptiques",
"item": "https://questionsmedicales.fr/mesh/D000073376"
},
{
"@type": "ListItem",
"position": 7,
"name": "Épilepsies myocloniques",
"item": "https://questionsmedicales.fr/mesh/D004831"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épilepsies myocloniques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épilepsies myocloniques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épilepsies myocloniques",
"description": "Comment diagnostiquer une épilepsie myoclonique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent une épilepsie myoclonique ?\nL'épilepsie myoclonique est-elle héréditaire ?\nQuel rôle joue l'EEG dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Single-Blind+Method#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épilepsies myocloniques",
"description": "Quels sont les symptômes principaux ?\nLes myoclonies sont-elles douloureuses ?\nPeut-on avoir des crises sans myoclonies ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes crises peuvent-elles survenir la nuit ?",
"url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Single-Blind+Method#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épilepsies myocloniques",
"description": "Peut-on prévenir les crises myocloniques ?\nQuels déclencheurs sont à éviter ?\nL'éducation est-elle importante pour la prévention ?\nLe suivi médical est-il essentiel ?\nLes activités physiques sont-elles sûres ?",
"url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Single-Blind+Method#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épilepsies myocloniques",
"description": "Quels médicaments sont utilisés pour traiter ?\nY a-t-il des traitements non médicamenteux ?\nComment évaluer l'efficacité du traitement ?\nLes traitements sont-ils à vie ?\nQuels effets secondaires des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Single-Blind+Method#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épilepsies myocloniques",
"description": "Quelles complications peuvent survenir ?\nL'épilepsie myoclonique peut-elle affecter la vie quotidienne ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles entraîner des accidents ?\nComment gérer les complications psychologiques ?",
"url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Single-Blind+Method#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épilepsies myocloniques",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque d'épilepsie myoclonique ?\nLes troubles neurologiques augmentent-ils le risque ?\nLe stress est-il un facteur de risque ?\nLes infections cérébrales sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D004831?mesh_terms=Single-Blind+Method#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une épilepsie myoclonique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, l'examen neurologique et l'EEG."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'EEG, l'IRM cérébrale et des tests sanguins peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une épilepsie myoclonique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des secousses musculaires rapides, souvent sans perte de conscience, sont typiques."
}
},
{
"@type": "Question",
"name": "L'épilepsie myoclonique est-elle héréditaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines formes peuvent être héréditaires, nécessitant une évaluation familiale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'EEG dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'EEG aide à détecter les anomalies électriques typiques des épilepsies myocloniques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des myoclonies, des crises généralisées et parfois des absences."
}
},
{
"@type": "Question",
"name": "Les myoclonies sont-elles douloureuses ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les myoclonies ne sont généralement pas douloureuses, mais peuvent être gênantes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des crises sans myoclonies ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent avoir des crises généralisées sans myoclonies."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la fréquence des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles survenir la nuit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des crises myocloniques peuvent survenir pendant le sommeil."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les crises myocloniques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un traitement adéquat et l'évitement des déclencheurs."
}
},
{
"@type": "Question",
"name": "Quels déclencheurs sont à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, la fatigue, et la consommation d'alcool peuvent déclencher des crises."
}
},
{
"@type": "Question",
"name": "L'éducation est-elle importante pour la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur la maladie aide les patients à mieux gérer leur condition."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il essentiel ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités peuvent être sûres, mais il faut éviter les sports à risque."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticonvulsivants comme le valproate et le lamotrigine sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme la thérapie comportementale et la diététique peuvent aider."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction des crises et les effets secondaires."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils à vie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, le traitement est à long terme, mais certains peuvent réduire ou arrêter."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des médicaments ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, vertiges et troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des blessures dues aux crises et des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "L'épilepsie myoclonique peut-elle affecter la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut impacter la vie sociale, professionnelle et la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de dépression ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes épileptiques ont un risque plus élevé de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles entraîner des accidents ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises peuvent provoquer des accidents, notamment lors de la conduite."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications psychologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un soutien psychologique et des thérapies adaptées peuvent aider à gérer ces complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les traumatismes crâniens et certaines infections sont des facteurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'épilepsie myoclonique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'épilepsie myoclonique peut débuter à tout âge, mais souvent dans l'enfance ou l'adolescence."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres troubles neurologiques peuvent augmenter le risque d'épilepsie myoclonique."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut déclencher des crises chez les personnes prédisposées."
}
},
{
"@type": "Question",
"name": "Les infections cérébrales sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme la méningite, peuvent augmenter le risque d'épilepsie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 23/04/2025
Contenu vérifié selon les dernières recommandations médicales
10 publications dans cette catégorie
Affiliations :
IRCCS Istituto "Giannina Gaslini", Genova, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
9 publications dans cette catégorie
Affiliations :
Department of Neurology, Drammen Hospital, Vestre Viken Health Trust, Oslo, Norway.
9 publications dans cette catégorie
Affiliations :
Department of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
MRC Centre for Neurodevelopmental Disorders, King's College London, UK.
King's College Hospital, London, UK.
Evelina London Children's Hospital, London, UK.
7 publications dans cette catégorie
6 publications dans cette catégorie
Affiliations :
Department of Neurology, Drammen Hospital, Vestre Viken Health Trust, Oslo, Norway.
University of Oslo, Oslo, Norway.
6 publications dans cette catégorie
Affiliations :
Department of Radiology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
6 publications dans cette catégorie
Affiliations :
Department of Neurology, Haeundae Paik Hospital, Inje University College of Medicine, Haeundae-ro 875, Haeundae-gu, Busan, 48108, Republic of Korea. smilepkm@hanmail.net.
5 publications dans cette catégorie
Affiliations :
Department of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
MRC Centre for Neurodevelopmental Disorders, King's College London, UK.
Publications dans "Épilepsies myocloniques" :
5 publications dans cette catégorie
Affiliations :
Cardiff & Vale University Health Board, UK.
Publications dans "Épilepsies myocloniques" :
5 publications dans cette catégorie
Affiliations :
Department of Clinical & Experimental Medicine, Pisa University Hospital, Italy.
Publications dans "Épilepsies myocloniques" :
5 publications dans cette catégorie
Affiliations :
Department of Basic & Clinical Neurosciences, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
MRC Centre for Neurodevelopmental Disorders, King's College London, UK.
King's College Hospital, London, UK.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Toronto Western Hospital, Canada.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Odense University Hospital, Odense, Denmark.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Division of Paediatric Neurology, Department of Paediatrics, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Odense University Hospital, Odense, Denmark.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Nationwide Children's Hospital, Ohio.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Danish Epilepsy Centre, Dianalund, Denmark.
University of Copenhagen, Denmark.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Norway.
National Centre for Epilepsy, Oslo University Hospital, Norway.
Publications dans "Épilepsies myocloniques" :
4 publications dans cette catégorie
Affiliations :
Newcastle upon Tyne NHS Foundation Trust, Newcastle, UK.
Publications dans "Épilepsies myocloniques" :
Submucosal tunnel endoscopic resection (STER) is an effective technique for treating esophageal submucosal tumors, but the efficacy and safety of treating esophageal submucosal tumors with internal tr...
Eighty patients who underwent STER for esophageal submucosal tumors were included in the study. They were randomized and assigned to the two groups. The dual-knife method was used for STER. Forty pati...
STER was successful in all cases. Lesion features and demographics were similar between the two groups. In addition, broad exposure of the submucosal tissue was obtained by applying tension to the sel...
This original study showed that esophageal submucosal tumors could be effectively and safely treated with internal traction method-assisted STER, and this technique might be superior to conventional S...
Dual antiplatelet therapy (DAPT) provides additional risk reduction of ischemic events compared to aspirin monotherapy, at cost of higher bleeding risk. There are few data comparing new techniques for...
This study investigated the effectiveness of the HemCon Dental Dressing (HDD) compared to oxidized cellulose gauze....
This randomized study included 60 patients on DAPT who required at least two dental extractions (120 procedures). Each surgical site was randomized to HDD or oxidized regenerated cellulose gauze as th...
Intra-oral bleeding time was lower in HDD compared with control (2 [2-5] vs. 5 [2-8] minutes, P=0.001). Prolonged postoperative bleeding was observed in 7 cases (11.6%), all of them successfully manag...
In patients on DAPT, HDD resulted in a lower intra-oral bleeding time compared to oxidized cellulose gauze after dental extractions. Moreover, HDD also seems to improve healing conditions....
Melatonin is effective for migraine prevention in adults. We hypothesized that melatonin would also be effective for migraine prevention in children and adolescents....
This was a randomized, double-blind trial of melatonin (3 mg or 6 mg) versus placebo for migraine prevention in 10-17 year-olds with 4-28/28 headache days at baseline. Participants were recruited from...
The study closed early due to slow enrollment (n = 72). Two participants were in the single-blind phase when the study closed, therefore the meaningful n = 70. Sixteen percent (11/70) were lost to fol...
When compared to recall at enrollment, headache days decreased across the single-blind placebo phase and the double-blind phase. There was no suggestion of superiority of melatonin; however, given the...
Ultrasound showed to improve the precision and efficacy of spinal anesthesia (SA) through the identification of specific structures surrounding the intrathecal space, such as the anterior and posterio...
This prospective single-blind observational study involved 100 patients undergoing orthopedic or urological surgery. A first operator chose by landmarks the intervertebral space where he wanted to per...
The ultrasound visualization of only posterior complex or the failure in visualization of both complexes showed a positive predictive value of 76% and 100%, respectively, towards difficult SA vs. 6% w...
Ultrasound showed a high accuracy in detecting difficult spinal anesthesia and its use should be recommended in the daily clinical practice in order to increase success rate and minimize patient disco...
Neurofeedback and transcranial Direct Current Stimulation (tDCS) are promising techniques for neuroenhancement of attentional performance. As far as we know no study compared both techniques on attent...
Innovation in the training of future physiotherapy professionals through the use of collaborative learning could be an effective method for developing advanced competencies such as professional ethics...
A prospective, assessor-blinded, controlled trial was performed. A 12-week program was carried out with future physiotherapy professionals. The cooperative learning group was based on group activities...
A total of 216 participants completed the study (cooperative group...
Cooperative learning showed a positive impact on developing advanced competencies such as knowledge and perception of knowledge regarding professional ethics. Both methodologies showed adequate result...
Continuous emission monitoring (CM) solutions promise to detect large fugitive methane emissions in natural gas infrastructure sooner than traditional leak surveys, and quantification by CM solutions ...
Although robotic telesurgery is growing in popularity, the benefits of telesurgery compared to local surgery are unclear. This study aimed to evaluate the performance of robotic tele-cholecystectomy w...
Low-volume preparations for colonoscopy are gaining attention for their higher acceptability. However, the efficacy and safety of oral sulfate solution (OSS) preparations in patients with ulcerative c...
A multicenter, randomized, single-blind study was conducted at six tertiary referral hospitals in Korea. Outpatients with UC who had stable disease activity were randomly allocated to the OSS group or...
The OSS and 2-L PEG+Asc groups included 92 and 93 participants, respectively. No significant between-group difference was noted in successful cleansing (OSS [96.7%] vs 2-L PEG+Asc [97.8%], p=0.64). Mo...
OSS is effective for colonoscopy cleansing, has acceptable tolerability, and does not affect disease activity; thus, it can be used safely for bowel preparation in patients with inactive UC....
Given that the consequences of treatment decisions for end-stage renal disease (ESRD) patients are long-term and significant, good communication skills are indispensable for health care personnel (HCP...
For this single-center, single-blind study, 91 participants (nephrologists and nephrology nurses) were randomly assigned to two groups, the intervention group (IG) (n = 45) or the control group (CG) (...
IG participants exhibited significantly higher truth-telling confidence at T1 than did CG participants (t = 2.833, P = .006, Cohen's d = 0.59), while there were no significant intergroup differences i...
ESRD CST enhanced short-term truth-telling confidence, though it is unclear whether this was due to CST content or the online delivery. However, during pandemics, when face-to-face training is unsuita...